Feed Preview

Autoimmune Disease Therapy

Autoimmune Disease Therapy diagram by Public Domain, Wikimedia
Public Domain, Wikimedia

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Top 20 most recent papers
Annals of Oncology : Official Journal of the European Society for Medical Oncology

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: Review of the literature and personalized risk-based prevention strategy

Annals of Oncology : Official Journal of the European Society for Medical OncologyMarch 21, 2020
J HaanenM Obeid
4
Journal of Thrombosis and Haemostasis : JTH

Management of Major Bleeds in Patients with Immune Thrombocytopenia

Journal of Thrombosis and Haemostasis : JTHMarch 29, 2020
Siraj MithoowaniDonald M Arnold
Expert Review of Gastroenterology & Hepatology

Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease

Expert Review of Gastroenterology & HepatologyMarch 29, 2020
Ruggiero FrancavillaMaria De Angelis
Seminars in Immunology

Peptide mimotopes alter T cell function in cancer and autoimmunity

Seminars in ImmunologyMarch 25, 2020
Jill E Slansky, Maki Nakayama
Current Rheumatology Reports

Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy

Current Rheumatology ReportsMarch 29, 2020
Alana NevaresRula Hajj-Ali
ImmunoTargets and Therapy

Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis

ImmunoTargets and TherapyMarch 27, 2020
Noha Mousaad ElemamAzzam A Maghazachi
International Journal of Molecular Sciences

Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview

International Journal of Molecular SciencesMarch 25, 2020
Novella RapiniAlessandra Fierabracci
Frontiers in Immunology

Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?

Frontiers in ImmunologyMarch 27, 2020
Vijaya Iragavarapu-CharyuluAlexandra Urdaneta
1

See more papers from this feed

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

© 2020 Meta ULC. All rights reserved
/feed-previews/autoimmune-disease-therapy/84fc4193-5049-4b97-ba3e-66873e41d77f